drugset / Trial / NCT02099006
Novel Topical Therapies for the Treatment of Genital Pain
Non-randomizedCrossoverDouble-blindTreatment
Summary
This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amitriptyline | Small molecule | 2 % | Topical |
| Subject | Baclofen | Small molecule | 2 % | Topical |
| Subject | Gabapentin | Small molecule | 6 % | Topical |
| Subject | Ketamine | Small molecule | 10 % | Topical |
| Subject | Ketoprofen | Small molecule | 10 % | Topical |
| Subject | Loperamide | Small molecule | 5 % | Topical |